Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...